Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer

The purpose of this study was to evaluate the prognostic ability of early changes of total prostate specific antigen (tPSA), free PSA (fPSA), [−2]proPSA and the Prostate Health Index (PHI) following initiation of Abiraterone-therapy in men with castration resistant prostate cancer (mCRPC). In 25 pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlack, Katrin, Krabbe, Laura-Maria, Fobker, Manfred, Schrader, Andres Jan, Semjonow, Axel, Boegemann, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037797/
https://www.ncbi.nlm.nih.gov/pubmed/27618028
http://dx.doi.org/10.3390/ijms17091520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037797/
https://www.ncbi.nlm.nih.gov/pubmed/27618028
http://dx.doi.org/10.3390/ijms17091520

Ejemplares similares